The
report titled “Singapore Healthcare Market Forecast to 2022 - by Type
of Clinics (Medical and Dental), by Hospitals (Private, Public and
Not-for-Profit), by Prescription and OTC Drugs, by type of Medical Devices
(Consumables, Diagnostic Imaging, Patient Aids, Orthopedics & Prosthetics,
Dental Products and Others)” provides information on market size for Singapore
hospital, pharmaceutical, pharmacy retail, clinics, Contract Research
Organization and medical devices. The report covers aspects such as, hospital
market segment (by public, private & not-for-profit hospitals, by Inpatient
& Outpatient and by Acute, Community & Psychiatry Hospitals),
pharmaceutical market segment (by Prescription & OTC Drugs, by Patented
& Generic Drugs), pharmacy retail market segment (by drugs & private
label goods and by region), CRO market segmentation (by Therapeutic Class &
by Clinical Trial Phase) and medical device market segment (by type of medical
device, and by end user), competitive landscape of major players in the Singapore
clinics market, hospital market, pharmaceutical market, pharmacy retail market,
clinical laboratory market, CRO market and medical devices market and covering
competitive landscape of major healthcare institutions including Singapore
Medical group, Q&M Dental Group, Singapore General Hospital, Ferrer Park, Changi
General Hospital, GSK, Singapore, Beacon pharmaceuticals, Guardian Pharmacy,
Unity Pharmacy, Singapore Clinical Research Institute, QT Vascular, Biosensors
International, National Healthcare Group Diagnostics, Innovative Diagnostics
and Radlink. The report concludes with market projections for future and
analyst recommendations highlighting the major opportunities and cautions.
Singapore Healthcare Market Overview
Singapore
has one of the best health infrastructures in the world. The population is
ageing and medical tourism will drive the demand for healthcare services in
Singapore in the near future. Most of the expensive tertiary care services are
provided by public hospitals at affordable rates. This is supported by the
implementation of MediShield Life which is the National Health Insurance
Scheme. Primary healthcare services are mostly provided by private sector
practitioners and some by government polyclinics operating under MOH. Public
hospitals and specialty centers engage in clinical research.
Market Segmentation
Singapore Hospital Market
Singapore
hospitals market increased at a declining rate during 2012-2017. Macro trends
positively affecting the hospital market include ageing population, rising
chronic disease prevalence, escalating healthcare needs and increasing
complexity of care needs.
Revenue
from outpatients have accounted for the major share in Singapore hospital
market in 2017 followed by revenue generated from inpatient services. This was
majorly due to shift in focus towards preventive healthcare services which
augmented the revenues from outpatient services.
Acute
hospitals have accounted for majority share in the number of hospitals and largest
proportion of beds in 2017 followed by Community and psychiatric hospitals.
Singapore Clinics Market
Singapore
clinics market increased at a positive CAGR during the review period. The
market is at a growing stage with major clinic groups undertaking inorganic
methods of expansion and widening their service portfolio.
Medical
clinics have accounted for the largest share in the overall revenue generated
by clinics in Singapore in 2017. This is majorly driven by organic and
inorganic expansion of large players and adoption of asset light model. Other
major types of clinics include dental clinics.
The
central region of Singapore has accounted for the largest number of the clinics
in Singapore in 2017 driven by high population, and greater connectivity with
other parts of Singapore. The north region has registered robust concentration
of number of clinics in Singapore in 2017. Within this region, Woodlands and
Yishun have most number of clinics offering dental and family medicine. This is
followed by east region, west region and south region.
Singapore Pharmaceutical Market
Singapore
Pharmaceutical market can be characterized by the presence of best-in-class
infrastructure, integrated and advanced hubs for pharmaceutical manufacturing
and research and access to regional markets and skilled workforce. Singapore
Pharmaceutical market has registered an increase in the revenue at a positive CAGR
during 2012-2017.
Prescription
drugs have accounted for the largest share in the revenue in Singapore
pharmaceutical market in 2017 driven by new brands, high prices for existing
drugs and fewer patent expiries. OTC drugs have accounted for the remaining
share of the revenue owing to rise in trend of self-medication in Singapore.
Patented
drugs have accounted for largest share in the revenue in Singapore prescription
drugs market in 2017. Generic drugs have accounted for the remaining share of
the revenue.
Singapore Pharmacy Retail Market
Singapore
pharmacy retail market revenue has escalated at a positive CAGR during
2012-2017.
Private
Label Goods have registered the largest share in the revenue share in Singapore
pharmacy retail market 2017. Drugs have accounted for the remaining share in
2017. The sale of prescription drug in Singapore is not high as the doctor is
allowed to sell those drugs at cheaper costs.
Central
Region has accounted for the largest number of the pharmacies in Singapore in
2017 due to the presence of large number of hospitals and clinics and supported
by high population. This is followed by north, east, west and south Singapore.
Singapore Medical Device Market
Singapore
Medical device market is in the growing stage with rise in number of foreign
players.
Medical
Consumables have accounted for the largest share in the revenue generated by
medical device market in Singapore in 2017. This is followed by diagnostic imaging
products, patient’s aids, orthopedic & prosthetics, dental products. Others
include Point of Care Testing devices, radiation oncology devices, therapy
system and testing and measurement systems.
Ministry
of Health which controls most of the hospitals and significant proportion of
the clinics in Singapore has accounted for largest share in the revenue
generated by medical devices in Singapore in 2017. Other healthcare
institutions such as private hospitals and clinical laboratories have accounted
for the remaining share.
Key Topics Covered in the Report:-
·
Singapore Clinics, Hospitals,
Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO Market Size, 2012-2017
·
Singapore Hospitals Market
Segmentation (by Public, Private Hospital & Not-for-Profit Hospital, by
Inpatient & Outpatient, by Acute, Community & Psychiatry Hospitals)
·
Singapore Clinics Market
Segmentation (By Type Of Clinic And By Region)
·
Singapore Medical Device
Market Segmentation (By Type Of Medical Device, And By End User)
·
Singapore Pharmaceutical
Market Segmentation (by Prescription & OTC Drugs, by Patented & Generic
Drugs)
·
Singapore Pharmacy Retail
Market Segmentation (by Drugs & Private Label Goods and By Region)
·
Singapore Clinics, Hospitals,
Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO Market Competitive Landscape
·
Singapore Clinics, Hospitals,
Pharmaceutical, Pharmacy Retail, Medical Devices, and CRO Market Future Outlook and Projections,
2018-2022
·
Analyst
Recommendations
For more information
about the publication, refer to below link:-
https://www.kenresearch.com/healthcare/general-healthcare/singapore-healthcare-market/154981-91.html
Related Reports:-
https://www.kenresearch.com/healthcare/general-healthcare/uae-healthcare-market-report/37505-91.html
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249
No comments:
Post a Comment